Myrexis, Inc. (MYRX) is a publicly traded company in the Financial Services sector, operating within the Shell Companies industry. The company is headquartered in New York City, NY, United States. The current CEO is Jonathan Couchman.
MYRX has IPO date of 2009-06-12, 1 full-time employees, listed on the Other OTC, a market capitalization of $20.69K.
Myrexis, Inc. focuses on identifying, evaluating, and making financial investments in life sciences assets. The company was formerly known as Myriad Pharmaceuticals, Inc. and changed its name to Myrexis, Inc. in July 2010. Myrexis, Inc. is headquartered in New York, New York.
